Hospitalist Doctors in Greensboro, NC Accepting Medicare

9 Hospitalist doctors found. Showing 1 - 9

Anand Hongalgi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Elm St, Greensboro, NC 27401 Phone: 336-832-4380    Fax: 336-832-4382

Dr. Christopher Oti, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Elm St, Greensboro, NC 27401 Phone: 336-832-4380    Fax: 336-832-4382

Nishant Dhungel, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1121 N. Church Street, Greensboro, NC 27401 Phone: 336-832-4320    Fax: 336-832-4382

Anastassia Doutova, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Elm St, Greensboro, NC 27401 Phone: 336-274-6515    Fax: 336-275-0812

Christopher Peter Danford, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Elm St, Greensboro, NC 27401 Phone: 336-832-4380

Dr. Jehanzeb Memon, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 104 Pomona Dr, Greensboro, NC 27407 Phone: 336-268-4100    Fax: 336-268-3158

Mackenzie E Short, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1200 N Elm St, 3rd Floor, Suite 3509, Greensboro, NC 27401 Phone: 336-832-2835

Sendil Krishnan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Elm St, Greensboro, NC 27401 Phone: 336-274-6515    Fax: 336-832-8717

Corinna Sullivan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Elm St, Greensboro, NC 27401 Phone: 336-274-6515    Fax: 336-832-8717

News Archive

Common heart drugs are safe for patients hospitalized with COVID-19

Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session today at ESC Congress 2020.

GRAVITAS Trial finds high dose of clopidogrel does not reduce risk of ischemic events

Accumetrics, Inc., developer and marketer of the VerifyNow System, today announced that the GRAVITAS (Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety) Trial found that in patients with high residual platelet reactivity, doubling the maintenance dose of clopidogrel did not reduce the risk of further ischemic events after percutaneous coronary intervention (PCI).

Pfizer and Cellectis enter into global strategic collaboration to develop CAR-T immunotherapies

Pfizer Inc. and Cellectis today announced that they have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets.

HCI unveils new mobile outreach vehicle to offer education, cancer screening services

Today Huntsman Cancer Institute at the University of Utah unveiled the Cancer Screening and Education bus.

Researchers can now predict fear memory formation

Psychologists at the University of Amsterdam (UvA) have discovered that changes in patterns of brain activity during fearful experiences predict whether a long-term fear memory is formed. The research results have recently been published in the prestigious scientific journal Nature Neuroscience.

Read more Medical News

› Verified 1 days ago